Works matching IS 13479032 AND DT 2009 AND VI 100 AND IP 1


Results: 27
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Japanese phase II study of <sup>90</sup>Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma.

    Published in:
    Cancer Science, 2009, v. 100, n. 1, p. 158, doi. 10.1111/j.1349-7006.2008.00999.x
    By:
    • Tobinai, Kensei;
    • Watanabe, Takashi;
    • Ogura, Michinori;
    • Morishima, Yasuo;
    • Hotta, Tomomitsu;
    • Ishizawa, Kenichi;
    • Itoh, Kuniaki;
    • Okamoto, Shin-ichiro;
    • Taniwaki, Masafumi;
    • Tsukamoto, Norifumi;
    • Okumura, Hirokazu;
    • Terauchi, Takashi;
    • Nawano, Shigeru;
    • Matsusako, Masaki;
    • Matsuno, Yoshihiro;
    • Nakamura, Shigeo;
    • Mori, Shigeo;
    • Ohashi, Yasuo;
    • Hayashi, Masaki;
    • Endo, Keigo
    Publication type:
    Article